- Home
- AGI vs CORT Comparison
AGI vs CORT Comparison
Compare AGI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGI
- CORT
- Stock Information
- Founded
- AGI 2003
- CORT 1998
- Country
- AGI Canada
- CORT United States
- Employees
- AGI N/A
- CORT N/A
- Industry
- AGI Precious Metals
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- AGI Basic Materials
- CORT Health Care
- Exchange
- AGI Nasdaq
- CORT Nasdaq
- Market Cap
- AGI 10.8B
- CORT 7.1B
- IPO Year
- AGI 1999
- CORT N/A
- Fundamental
- Price
- AGI $26.17
- CORT $75.80
- Analyst Decision
- AGI Buy
- CORT Strong Buy
- Analyst Count
- AGI 4
- CORT 4
- Target Price
- AGI $30.38
- CORT $142.00
- AVG Volume (30 Days)
- AGI 4.2M
- CORT 1.2M
- Earning Date
- AGI 04-30-2025
- CORT 05-05-2025
- Dividend Yield
- AGI 0.38%
- CORT N/A
- EPS Growth
- AGI 19.70
- CORT 8.36
- EPS
- AGI 0.62
- CORT 1.14
- Revenue
- AGI $1,402,300,000.00
- CORT $685,446,000.00
- Revenue This Year
- AGI $30.00
- CORT $35.85
- Revenue Next Year
- AGI $10.74
- CORT $35.22
- P/E Ratio
- AGI $42.41
- CORT $66.36
- Revenue Growth
- AGI 33.63
- CORT 30.93
- 52 Week Low
- AGI $15.01
- CORT $27.30
- 52 Week High
- AGI $31.00
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- AGI 48.25
- CORT 58.35
- Support Level
- AGI $23.75
- CORT $68.86
- Resistance Level
- AGI $24.56
- CORT $75.50
- Average True Range (ATR)
- AGI 0.77
- CORT 3.09
- MACD
- AGI -0.12
- CORT 0.36
- Stochastic Oscillator
- AGI 57.77
- CORT 88.00
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.